ArticleJournal for immunotherapy of cancer2026

Evaluating the safety of Janus kinase inhibitors in the management of severe immune-related adverse events.

Eudora Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.